Persistently Gadolinium-Enhancing Lesion Is a Predictor of Poor Prognosis in NMOSD Attack: a Clinical Trial

MLA

Wangshu Xu, et al. “Persistently Gadolinium-Enhancing Lesion Is a Predictor of Poor Prognosis in NMOSD Attack: A Clinical Trial.” Neurotherapeutics, vol. 18, Jan. 2021, pp. 868–77. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a318a5532aabc9024e85fa327b59be4a&authtype=sso&custid=ns315887.

APA

Wangshu Xu, Xindi Li, Yun Xu, Yaou Liu, De-Cai Tian, Xinghu Zhang, Xinli Wang, Yi Ren, & Yunyun Duan. (2021). Persistently Gadolinium-Enhancing Lesion Is a Predictor of Poor Prognosis in NMOSD Attack: a Clinical Trial. Neurotherapeutics, 18, 868–877.

Chicago

Wangshu Xu, Xindi Li, Yun Xu, Yaou Liu, De-Cai Tian, Xinghu Zhang, Xinli Wang, Yi Ren, and Yunyun Duan. 2021. “Persistently Gadolinium-Enhancing Lesion Is a Predictor of Poor Prognosis in NMOSD Attack: A Clinical Trial.” Neurotherapeutics 18 (January): 868–77. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a318a5532aabc9024e85fa327b59be4a&authtype=sso&custid=ns315887.